Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

6 Stocks To Watch For July 13, 2017

CBSH, DAL, TSM, MCKPF, BOX

Some of the stocks that may grab investor focus today are:

  • Wall Street expects Delta Air Lines, Inc. (NYSE: DAL) to report quarterly earnings at $1.66 per share on revenue of $10.78 billion before the opening bell. Delta Air shares gained 1.39 percent to $56.25 in after-hours trading.
  • Box Inc (NYSE: BOX) named Stephanie Carullo as its new Chief Operating Officer. Box shares rose 0.59 percent to $18.78 in the after-hours trading session.
  • Analysts are expecting Commerce Bancshares, Inc. (NASDAQ: CBSH) to have earned $0.7 per share on revenue of $306.04 million in the recent quarter. Commerce Bancshares will release earnings before the markets open. Commerce Bancshares shares fell 0.30 percent to close at $56.24 on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • DragonWave Inc. (NASDAQ: DRWI) reported a Q1 loss of $0.52 per share on revenue of $9 million. DragonWave shares dipped 28.35 percent to $0.78 in the after-hours trading session.
  • Analysts expect Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE: TSM) to report quarterly earnings at $0.54 per share on revenue of $7.52 billion before the opening bell. TSM shares gained 0.87 percent to $36.00 in after-hours trading.
  • Mallinckrodt PLC (NYSE: MNK) disclosed that the FDA Granted orphan drug designation for potential DMD treatment. Mallinckrodt shares gained 2.27 percent to $45.10 in the after-hours trading session.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today